Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
American Pharma SummitAmerican Pharma Summit
Not Confirmed
Not Confirmed
18-19 November, 2024
Pharma Manufacturing 2...Pharma Manufacturing 2024
Not Confirmed
Not Confirmed
18-19 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
American Pharma SummitAmerican Pharma Summit
Industry Trade Show
Not Confirmed
18-19 November, 2024
Pharma Manufacturing 2...Pharma Manufacturing 2024
Industry Trade Show
Not Confirmed
18-19 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
14 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/huyabio-validates-protective-mechanism-for-antiarrhythmic-drug-hbi-3000-in-af-patients-paving-the-way-for-a-new-era-in-atrial-fibrillation-treatment-302305051.html
08 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/huyabio-presents-positive-phase-2-data-on-hbi-8000-and-nivolumab-combination-for-advanced-melanoma-302300026.html
31 Aug 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/huyabio-files-an-investigational-new-drug-application-with-the-fda-for-the-novel-shp2-inhibitor-hbi-2376-301365878.html
09 Nov 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/huya-bioscience-international-presents-positive-data-on-hbi-8000-at-society-for-immunotherapy-of-cancer-meeting-301168347.html
05 Aug 2020
// PRESS RELEASE
https://www.huyabio.com/huya-bioscience-international-licenses-the-novel-shp2-inhibitor-hbi-2376-for-development-in-oncology/
04 Aug 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/huya-bioscience-international-licenses-the-novel-shp2-inhibitor-hbi-2376-for-development-in-oncology-301105367.html
ABOUT THIS PAGE
HUYA Bioscience International is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of Chidamide bulk offered by HUYA Bioscience International
Find a price of Tucidinostat bulk offered by HUYA Bioscience International
LOOKING FOR A SUPPLIER?